You are here

P&T® Journal contents for June 2004


Meeting Highlights
The author summarizes a few of the many sessions attended by more than 25,000 mental health professionals, specifically, the effect of medications on cholesterol levels as well as advances in pharmacotherapy for attention-deficit/hyperactivity disorder, major depression, and Alzheimer’s disease.
Reuben B. David
Dr. Wool compares the features of traditional Medicare with the new prescription drug coverage, as outlined in the Medicare Modernization Act of 2003, and emphasizes the need to continue working to improve the program.
Marvin S. Wool, MD, MPH
The author reviews the efficacy of beta blockade for patients undergoing noncardiac surgery who are at risk for myocardial infarction, unstable angina, congestive heart failure, and cardiac death.
Andrew D. Auerbach, MD, MPH
Book Review
A worthwhile book provides real-life examples of serious medical errors and stresses the need for more safeguards to prevent them from occurring.
Adam Evans


David Nash, MD, MBA, discusses a new Web site that provides educational materials on diabetes for health care professionals, P&T committee members, and the public.
Prescription: Washington
Stephen Barlas discusses “ protected” electronic health information and the efforts of employers to secure data in compliance with HIPAA requirements.
Stephen Barlas
Medication Errors
Matthew Grissinger, RPh, FASCP, reviews the pitfalls of automatic stop-order policies.
Matthew Grissinger, RPh, FASCP
P&T presents the latest studies and information about FDA approvals, drug indications, industry updates, and new devices.
Drug Forecast
The authors review transdermal oxybutynin (Oxytrol®) for the treatment of overactive bladder.
Vitalina Rozenfeld, PharmD, BCPS, Stanley Zaslau, MD, Kathleen New Geissel, PharmD, David Lucas, PhD, and Lili Babazadeh, PharmD